Trimetazidine (Completed) Prevention of angina following PCI with trimetazidine MR 35 mg in patients with coronary artery disease Medicine trimetazidine MR Vastarel Population ASCVD Phase III Starting year 2011 Director of Study drs. C. van der Zwaan (Cardioloog) Tiel, Rivierenland